|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | A Review Of Anticancer Treatment Therapy |
| Authors Name: | Aniket Himmat Bhamare , Mrs. Dipika H. Patil , Hemraj Kondaji Jadhav , Lalit Bhausaheb Aher , Nilesh Prakash Pawar |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_187452
|
| Published Paper Id: | IJNRD2302138 |
| Published In: | Volume 8 Issue 2, February-2023 |
| DOI: | |
| Abstract: | Along with heart disease, cancer is one of the main causes of death in the US. Conventional chemotherapy has always been the cornerstone of cancer care. Chemotherapeutic medications are made to target cells that divide quickly, such as cancer cells, as well as some normal cells, such the intestinal epithelium. A new generation of cancer medicines, known as targeted cancer therapies, has emerged in recent years. Targeted cancer therapies, like traditional chemotherapy, employ pharmacological drugs that prevent growth, boost cell death, and limit the spread of cancer. Targeted therapies, as their name implies, prevent particular proteins implicated in cancer from doing their jobs. For many cancer types, including lung, colorectal, breast, lymphoma, and leukaemia, targeted cancer therapies may be more therapeutically helpful than broad-based cancer treatments because they concentrate on specific molecular changes that are specific to a particular malignancy. In addition, new developments have made it possible to assess patient tumors and customise therapies accordingly. Targeted cancer therapies primarily fall into one of three categories: monoclonal antibodies, small chemical inhibitors, or immunotoxins. The biology of these three groups of targeted cancer medicines will also be covered in detail in this review. |
| Keywords: | Apoptosis, chemotherapy, and medicines Antisense oligonucleotides and ionising radiation Ribozymes with dominant-negative mutations. |
| Cite Article: | "A Review Of Anticancer Treatment Therapy", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 2, page no.b372-b385, February-2023, Available :http://www.ijnrd.org/papers/IJNRD2302138.pdf |
| Downloads: | 000118752 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2302138 Registration ID: 187452 Published In: Volume 8 Issue 2, February-2023 DOI (Digital Object Identifier): Page No: b372-b385 Country: Kalwan, maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2302138 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2302138 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn